Drug co-developed by Mass. company slows Alzheimer's, researchers say
An experimental Alzheimer's drug co-developed by Cambridge-based Biogen slowed the brain disease's inevitable worsening, researchers reported.
Source: wcvb.com
Stay updated with breaking news from January Every. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
An experimental Alzheimer's drug co-developed by Cambridge-based Biogen slowed the brain disease's inevitable worsening, researchers reported.